Sotrovimab Reduces Hospitalization, Death In Patients With COVID-19, Study Finds

June 22, 2021

Reuters (6/21, Chander) reports GlaxoSmithKline and Vir Biotechnology on Monday “said...final results from a late-stage study of their monoclonal antibody,” sotrovimab, “confirmed it significantly reduced hospitalization and death among high-risk COVID-19...